Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FAF54
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,273
Award facts
- Contract value 100% obligated
- $10,273.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 25, 2025, is scheduled for completion by October 17, 2025, with performance at the vendor's facility in Park Ridge, Illinois. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its woman-owned small business status.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that serves as a critical supplier within the federal pharmaceutical supply chain. The company holds a substantial single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, under which this delivery order was issued. This underlying contract vehicle enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. The award of this delivery order reflects the vendor's established capability and reliability in delivering specialized pharmaceutical products to military health systems.
Quick answers
Who was awarded contract SPE2DB25FAF54?
SPE2DB25FAF54 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FAF54 worth?
The government has obligated $10,273 on SPE2DB25FAF54.
Is contract SPE2DB25FAF54 an order under another contract?
Yes. SPE2DB25FAF54 is a delivery order under SPE2DB22D9309, an indefinite delivery contract.
Was contract SPE2DB25FAF54 competed?
The extent of competition for SPE2DB25FAF54 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award